We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

By LabMedica International staff writers
Posted on 29 Apr 2016
Print article
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).
Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce.

Investigators at the Hebrew University of Jerusalem (Israel) and their colleagues at the Hadassah Medical Center (Jerusalem, Israel) focused this proof-of-concept study on the anticonvulsant drug carbamazepine, which is ubiquitously detected in reclaimed wastewater, highly persistent in soil, and taken up by crops.

They worked with 34 people who were divided into two groups. The first group was given reclaimed wastewater-irrigated produce for the first week, and freshwater-irrigated vegetables in the following week. The second group consumed the produce in reverse order. The investigators measured carbamazepine levels in the fresh produce and in the participants' urine.

Results published in the March 29, 2016, online edition of the journal Environmental Science and Technology revealed that individuals who consumed reclaimed wastewater-irrigated produce excreted carbamazepine and its metabolites in their urine, while subjects who consumed fresh water-irrigated produce excreted undetectable or significantly lower levels of carbamazepine.

This “proof of concept” study demonstrated that human exposure to xenobiotics occurred through ingestion of reclaimed wastewater-irrigated produce, providing real world data, which could guide risk assessments and policy designed to ensure the safe use of wastewater for crop irrigation.

"In a randomized controlled trial we have demonstrated that healthy individuals consuming reclaimed wastewater-irrigated produce excreted carbamazepine and its metabolites in their urine, while subjects consuming fresh water-irrigated produce excreted undetectable or significantly lower levels of carbamazepine," said first author Dr. Ora Paltiel, director of the school of public health and community medicine at the Hadassah Medical Center. "Treated wastewater-irrigated produce exhibited substantially higher carbamazepine levels than fresh water-irrigated produce. It is evident that those who consume produce grown in soil irrigated with treated wastewater increase their exposure to the drug. Though the levels detected were much lower than in patients who consume the drug, it is important to assess the exposure in commercially available produce."

Related Links:
Hebrew University of Jerusalem
Hadassah Medical Center
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.